GlassScriptPhysician profile
Sushil R Patil
NPI 1821095738
$4,406.02
in general payments reported to CMS, 2019-2025
40 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $182 · 2021: $503 · 2022: $1,049 · 2023: $712 · 2024: $984 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,414 · Education: $34.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,414.06 |
| Education | $34.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $996.81 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $527.95 | 2020-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $435.69 | 2019-2025 | Stelara, Tremfya, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $311.51 | 2021-2025 | Entyvio, Eohilia |
| Pfizer INC. | $286.56 | 2019-2025 | |
| Qol Medical, LLC | $181.94 | 2019-2025 | Sucraid, Sucraid |
| Braintree Laboratories, INC. | $158.99 | 2019-2025 | Suflave, Sutab |
| Medtronic, INC. | $156.15 | 2022-2023 | Gi Genius |
| Genzyme Corporation | $126.80 | 2023-2025 | |
| Aimmune Therapeutics, INC. | $110.31 | 2024-2025 | Zenpep |
| Lilly USA, LLC | $108.62 | 2024-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $107.86 | 2022-2024 | Dificid |
| Ferring Pharmaceuticals INC. | $86.09 | 2020-2023 | Rebyota |
| Regeneron Healthcare Solutions, INC. | $75.54 | 2022-2024 | Dupixent |
| Celltrion USA INC. | $66.56 | 2024-2025 | Zymfentra, Vegzelma |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $63.77 | 2022-2024 | Zeposia |
| Nestle Healthcare Nutrition INC. | $63.09 | 2023 | |
| Ironwood Pharmaceuticals, INC | $57.88 | 2019-2022 | |
| Daiichi Sankyo INC. | $50.95 | 2021-2024 | Injectafer |
| Intercept Pharmaceuticals, INC. | $46.29 | 2023-2024 | Ocaliva |
| Organon LLC | $45.77 | 2023 | Renflexis, Hadlima |
| Gilead Sciences, INC. | $37.78 | 2019 | |
| Baxter Healthcare | $33.76 | 2022 | |
| Phathom Pharmaceuticals, INC. | $33.62 | 2024 | Voquezna |
| Micro-Tech Endoscopy USA, INC. | $29.19 | 2024 | Biopsy Forceps |
| Alnylam Pharmaceuticals INC. | $23.76 | 2023 | Givlaari |
| Shionogi INC | $23.19 | 2019 | |
| Novo Nordisk INC | $21.98 | 2025 | Wegovy |
| Ardelyx, INC. | $19.94 | 2025 | Ibsrela |
| Amgen INC. | $18.40 | 2022 | |
| Madrigal Pharmaceuticals | $16.77 | 2024 | Resmetirom |
| Mylan Institutional INC. | $15.70 | 2023 | Hulio |
| Redhill Biopharma INC. | $14.99 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.60 | 2022 | |
| Shire North American Group INC | $13.36 | 2019 | |
| Echosens North America, INC. | $12.50 | 2025 | Fibroscan |
| Medtronic USA, INC. | $12.35 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushil Patil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.